Jay Flaherty

Member – VSCP Strategic Advisory Board


Jay is Member of the VSCP Strategic Advisory Board.  Mr. Flaherty is former Managing Partner of NorthStar Healthcare Finance. Previous to joining NorthStar, Mr. Flaherty was the Chairman and CEO of HCP, Inc., from 2003 to 2013. During his tenure at HCP, Mr. Flaherty grew HCP’s equity market capitalization tenfold, from approximately $2 billion in 2003 to over $20 billion in 2013, becoming the third largest REIT in the United States, the first healthcare REIT selected to the S&P 500 and the only REIT in the world selected to the S&P 500 “Dividend Aristocrats” Index. During Mr. Flaherty’s tenure at HCP, average shareholder returns exceeded 15% per year.

Previous to joining HCP, Mr. Flaherty served at Merrill Lynch & Co. for 19 years in a variety of investment banking, capital markets and private equity functions in New York, London, Los Angeles and was head of Merrill Lynch’s Global Healthcare Group, where he established and led Merrill Lynch’s healthcare franchise.  Throughout his career with Merrill Lynch, Mr. Flaherty developed significant corporate finance and mergers and acquisitions expertise along with substantial relationships with senior healthcare executives.  In addition, from 1995 to 2001, Mr. Flaherty was a member of Merrill Lynch’s Investment Banking Operating Committee.  Mr. Flaherty was associated with the accounting firm of Ernst & Whinney in its Boston office from 1979 to 1981 where he was a Certified Public Accountant.

Mr. Flaherty has served on the Board of Directors of Quest Diagnostics, a leading national provider of diagnostic testing, information and services.  Since 2007, Mr. Flaherty served as a member of the Board of Trustees at The University of Notre Dame.  Mr. Flaherty received a BBA in accounting from the University of Notre Dame and earned an M.B.A. from the Graduate School of Management at the University of California, Los Angeles.